We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

113 hedge funds and large institutions have $385M invested in Cullinan Oncology in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 24

64% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 14

12% more capital invested

Capital invested by funds: $344M → $385M (+$41M)

7% more funds holding

Funds holding: 106 → 113 (+7)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.62% less ownership

Funds ownership: 88.93% → 88.31% (-0.62%)

12% less call options, than puts

Call options by funds: $97K | Put options by funds: $110K

Holders
113
Holders Change
+7
Holders Change %
+6.6%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
45
Reduced
24
Closed
14
Calls
$97K
Puts
$110K
Net Calls
-$13K
Net Calls Change
+$467K

Top Buyers

Rank Fund Capital Flow
1
BOCH
Blue Owl Capital Holdings
New York
+$30.3M
2
Morgan Stanley
Morgan Stanley
New York
+$13.8M
3
Deutsche Bank
Deutsche Bank
Germany
+$4.79M
4
Franklin Resources
Franklin Resources
California
+$3.46M
5
AAA
Affinity Asset Advisors
New York
+$2.66M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10.4M
2
BC
Boxer Capital
California
-$9.72M
3
B
Braidwell
Connecticut
-$5.92M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$5.51M
5
KCM
Kennedy Capital Management
Missouri
-$2.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
MB
1
MPM BioImpact
Massachusetts
$77.9M – – –
BOCH
2
Blue Owl Capital Holdings
New York
$34.8M +$30.3M +3,419,842 New
Franklin Resources
3
Franklin Resources
California
$33.4M +$3.46M +390,505 +14%
BI
4
BVF Inc
California
$32.6M – – –
BlackRock
5
BlackRock
New York
$25.1M +$2M +225,989 +10%
Morgan Stanley
6
Morgan Stanley
New York
$18.7M +$13.8M +1,556,382 +549%
Vanguard Group
7
Vanguard Group
Pennsylvania
$18.1M +$734K +82,910 +5%
B
8
Braidwell
Connecticut
$12.6M -$5.92M -668,000 -35%
AIG
9
American International Group
New York
$12.6M +$8.61K +972 +0.1%
NI
10
Nextech Invest
Switzerland
$12.4M – – –
Citadel Advisors
11
Citadel Advisors
Florida
$11.5M +$601K +67,841 +6%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$9.33M +$1.04M +117,042 +15%
TCM
13
Tang Capital Management
California
$7.86M +$1.33M +150,000 +24%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$6.68M +$574K +64,841 +11%
RCMNY
15
Rubric Capital Management (New York)
New York
$6.39M – – –
State Street
16
State Street
Massachusetts
$5.76M +$385K +43,508 +8%
Deutsche Bank
17
Deutsche Bank
Germany
$5.56M +$4.79M +540,967 +11,717%
O
18
OrbiMed
New York
$5.55M – – –
PHP
19
Parkman Healthcare Partners
Connecticut
$5.4M +$807K +91,132 +21%
AAA
20
Affinity Asset Advisors
New York
$3.06M +$2.66M +300,000 New
Northern Trust
21
Northern Trust
Illinois
$2.72M +$107K +12,105 +5%
Renaissance Technologies
22
Renaissance Technologies
New York
$2.69M +$367K +41,388 +19%
Charles Schwab
23
Charles Schwab
California
$2.51M +$148K +16,719 +7%
Millennium Management
24
Millennium Management
New York
$2.38M -$56.3K -6,359 -3%
Hudson Bay Capital Management
25
Hudson Bay Capital Management
Connecticut
$2.29M – – –
1
2 3 4 5

CGEM Hedge Fund Activity: Q4 2023 in Review

113 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q4 2023, worth a combined $385M — up 12% from $344M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CGEM positions and 14 closed out — a net gain of 9 holders — while 45 added to existing stakes and 24 trimmed.

The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $30.3M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $10.4M sold.

  • 113 institutional investors held Cullinan Oncology (CGEM) as of Q4 2023, up from 106 in Q3 2023.
  • Funds reported $385M of Cullinan Oncology stock for Q4 2023, up 12% quarter-over-quarter.
  • 23 funds opened new Cullinan Oncology positions in Q4 2023 and 14 closed out, a net change of +9 holders.
  • The largest Cullinan Oncology buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $30.3M added.
  • The largest Cullinan Oncology seller in Q4 2023 was Adage Capital Partners, an estimated $10.4M sold.

Based on aggregated 13F filings for Q4 2023.